FDA Inspection 1025648 — Peter A. Kaufman, MD
The FDA completed an inspection of Peter A. Kaufman, MD on July 21, 2017 in Lebanon, NH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lebanon, NH (United States)
Additional Details
Clinical Investigator (CI)